https://links.sgx.com/FileOpen/Alita%20-%20Circular%20to%20Shareholders%20-%203%20Feb%202023.ashx?App=Announcement&FileID=745690
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%